HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Zanesi Selected Research

fragile histidine triad protein

1/2016Reduction in squamous cell carcinomas in mouse skin by dietary zinc supplementation.
1/2013Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.
4/2006Early loss of Fhit in the respiratory tract of rodents exposed to environmental cigarette smoke.
12/2005A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
8/2005Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
11/2004Inactivation of the FHIT gene favors bladder cancer development.
3/2004Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola Zanesi Research Topics

Disease

37Neoplasms (Cancer)
12/2018 - 09/2003
6Lung Neoplasms (Lung Cancer)
05/2016 - 08/2005
6Carcinogenesis
01/2014 - 08/2005
5Neoplasm Metastasis (Metastasis)
08/2015 - 07/2010
5Leukemia
01/2013 - 12/2009
4Lymphoma (Lymphomas)
08/2015 - 05/2006
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2013 - 01/2006
3Breast Neoplasms (Breast Cancer)
12/2016 - 06/2013
3Carcinoma (Carcinomatosis)
12/2006 - 11/2004
2Colonic Neoplasms (Colon Cancer)
01/2014 - 06/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2010 - 06/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2010 - 11/2004
1Cachexia
12/2018
1Lewis Lung Carcinoma
12/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2018
1Triple Negative Breast Neoplasms
12/2016
1Skin Neoplasms (Skin Cancer)
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016
1Central Nervous System Neoplasms
08/2015
1Glioblastoma (Glioblastoma Multiforme)
08/2015
1Medulloblastoma
08/2015
1Colorectal Neoplasms (Colorectal Cancer)
01/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2012
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2009
1Monoclonal Gammopathy of Undetermined Significance
09/2008
1Multiple Myeloma
09/2008
1Alopecia (Baldness)
05/2006
1Skin Diseases (Skin Disease)
05/2006
1Alopecia Areata
05/2006
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2006
1T-Cell Leukemia (Leukemia, T Cell)
01/2006
1Infections
10/2005
1Stomach Neoplasms (Stomach Cancer)
08/2005
1Hematologic Neoplasms (Hematological Malignancy)
08/2005

Drug/Important Bio-Agent (IBA)

19MicroRNAs (MicroRNA)IBA
12/2018 - 05/2006
11Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2006
7CarcinogensIBA
01/2016 - 09/2003
7fragile histidine triad proteinIBA
01/2016 - 03/2004
4Biomarkers (Surrogate Marker)IBA
04/2018 - 07/2012
4Histidine (L-Histidine)FDA Link
01/2016 - 03/2004
3Pharmaceutical PreparationsIBA
05/2016 - 10/2005
3ZincIBA
01/2016 - 08/2005
3DNA (Deoxyribonucleic Acid)IBA
06/2013 - 10/2007
3nitrosobenzylmethylamineIBA
03/2011 - 09/2003
3WW Domain-Containing OxidoreductaseIBA
07/2010 - 10/2005
2Biological ProductsIBA
04/2018 - 06/2013
2NucleolinIBA
12/2016 - 07/2015
2Paclitaxel (Taxol)FDA LinkGeneric
05/2016 - 01/2013
2Annexin A4IBA
05/2016 - 01/2013
2MethyltransferasesIBA
06/2013 - 10/2007
2Protein Tyrosine PhosphatasesIBA
12/2011 - 06/2006
1Toll-Like Receptor 7IBA
12/2018
1Caspase 3 (Caspase-3)IBA
12/2018
1Pancreatic Ribonuclease (Ribonuclease A)IBA
12/2016
1Monoclonal AntibodiesIBA
12/2016
1AntigensIBA
12/2016
1AnnexinsIBA
05/2016
1Peptides (Polypeptides)IBA
05/2016
1Tetradecanoylphorbol AcetateIBA
01/2016
1benz(a)anthracene (benzanthracene)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
08/2015
1Antineoplastic Agents (Antineoplastics)IBA
07/2015
1Differentiation AntigensIBA
12/2014
1Poly I-CIBA
06/2013
1Toll-Like Receptor 3IBA
06/2013
1Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2013
1retinoic acid receptor betaIBA
06/2013
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2013
1LigandsIBA
07/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2012
1NucleotidesIBA
07/2012
1Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA
12/2011
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2011
1Messenger RNA (mRNA)IBA
04/2010
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2010
1rofecoxib (Vioxx)FDA Link
03/2010
1Genetic Markers (Genetic Marker)IBA
03/2010
1OligonucleotidesIBA
12/2009
1mouse MIRN29 microRNAIBA
12/2009
1EnzymesIBA
10/2007
1ErbB Receptors (EGF Receptor)IBA
12/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2006
1Growth Factor ReceptorsIBA
12/2006
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2006
1T-Cell Acute Lymphocytic Leukemia Protein 1IBA
06/2006
1Acetylcysteine (Siran)FDA LinkGeneric
05/2006
1Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2006
1Budesonide (Pulmicort)FDA LinkGeneric
05/2006
1Benzo(a)pyreneIBA
05/2006
1imidazole mustard (BIC)IBA
05/2006
1SmokeIBA
04/2006
1Sirolimus (Rapamycin)FDA Link
01/2006
1ponasterone AIBA
10/2005

Therapy/Procedure

8Therapeutics
12/2018 - 03/2004
1Immunotherapy
12/2016
1Drug Therapy (Chemotherapy)
07/2010
1Oral Administration
05/2006
1Chemoprevention
05/2006